menu
    • menu

    Company profile for Iteos Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Iteos Therapeutics is a privately held, clinical-stage biopharmaceutical company dedicated to extending and improving the lives of people with cancer by designing and developing best-in-class immunotherapies. The Company has advanced EOS100850, an insurmountable, highly-selective and non-brain penetrant adenosine A2A receptor antagonist, into a Phase I clinical trial in January 2019. iTeos’s second clinical program, a fully ...
    Iteos Therapeutics is a privately held, clinical-stage biopharmaceutical company dedicated to extending and improving the lives of people with cancer by designing and developing best-in-class immunotherapies. The Company has advanced EOS100850, an insurmountable, highly-selective and non-brain penetrant adenosine A2A receptor antagonist, into a Phase I clinical trial in January 2019. iTeos’s second clinical program, a fully human, ADCC-enabling anti-TIGIT antibody (EOS884448) is expected to enter the clinic in the second half of 2019.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Iteos TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    139 Main Street Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.iteostherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/iteos-therapeutics-sa
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/iteostx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    iTeos Enters into Agreement to Be Acquired by Concentra Bio
    iTeos Enters into Agreement to Be Acquired by Concentra Bio

    23 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/21/3118625/0/en/iTeos-Therapeutics-Enters-into-Agreement-to-Be-Acquired-by-Concentra-Biosciences-for-10-047-in-Cash-per-Share-Plus-a-Contingent-Value-Right.html

    GLOBENEWSWIRE
    23 Jul 2025
    Share Share
    Concentra Bio to Acquire iTeos Therapeutics for $10.047/Share
    Concentra Bio to Acquire iTeos Therapeutics for $10.047/Share

    21 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/21/3118625/0/en/iTeos-Therapeutics-Enters-into-Agreement-to-Be-Acquired-by-Concentra-Biosciences-for-10-047-in-Cash-per-Share-Plus-a-Contingent-Value-Right.html

    GLOBENEWSWIRE
    21 Jul 2025
    Share Share
    iTeos To Close Down After TIGIT Fail
    iTeos To Close Down After TIGIT Fail

    29 May 2025

    // BIOSPACE

    https://www.biospace.com/business/iteos-to-close-down-after-tigit-fail

    BIOSPACE
    29 May 2025
    Share Share
    iTeos Therapeutics to Wind Down Operations
    iTeos Therapeutics to Wind Down Operations

    28 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/28/3089457/0/en/iTeos-Therapeutics-Announces-Its-Intention-to-Wind-Down-Operations.html

    GLOBENEWSWIRE
    28 May 2025
    Share Share
    GSK, partner iTeos scrap development of lung cancer therapy
    GSK, partner iTeos scrap development of lung cancer therapy

    14 May 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/iteos-gsk-discontinue-lung-cancer-therapy-development-2025-05-13/

    REUTERS
    14 May 2025
    Share Share
    iTeos Shares Interim Lung Study Results for Belrestotug
    iTeos Shares Interim Lung Study Results for Belrestotug

    13 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3080020/0/en/iTeos-Reports-Topline-Interim-Results-from-GALAXIES-Lung-201-Study-of-Belrestotug-Dostarlimab-in-First-Line-PD-L1-High-Non-Small-Cell-Lung-Cancer-Patients.html

    GLOBENEWSWIRE
    13 May 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search